The effectiveness of moxifloxacin in the treatment of community-acquired pneumonia
The article presents the results of domestic and international studies of the use of the fourth-generation fluoroquinolone moxifloxacin in the treatment of commu-nity-acquired pneumonia and pneumonia caused by SARS-CoV-2. Analysis of the clinical use of moxifloxacin in the treatment of complication...
Saved in:
Main Authors: | , , |
---|---|
Format: | article |
Language: | RU UK |
Published: |
Interdisciplinary Academy of Pain Medicine
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/7fad54fdfbf54f1ca15f44a7e80513d8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!